| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/22/2002 | US20020115076 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
| 08/22/2002 | US20020115074 Analyzing nucleic acids in samples; obtain nucleotide sequences, pool, incubate with primers, hybridize, determine concentration of preferential nucleotide sequences |
| 08/22/2002 | US20020115073 Genome-based personalized medicine |
| 08/22/2002 | US20020115072 Probe bound substrate, process for manufacturing same, probe array, method of detecting target substance, method of specifying nucleotide sequence of single-stranded nucleic acid in sample, and quantitative determination of target substance in sample |
| 08/22/2002 | US20020115071 Monitoring molecular weight adjustment in ionic compound; obtain chemical intermediates, incubate with fluorescent dyes, monitor fluorescence polarization to detect molecular weight adjustment |
| 08/22/2002 | US20020115070 Methods and apparatus for analyzing gene expression data |
| 08/22/2002 | US20020115068 Matrix screening method |
| 08/22/2002 | US20020115067 Asymmetric benzoxanthene dye labelling reagents |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020115062 Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020115059 Drug screening system |
| 08/22/2002 | US20020115057 Process for identifying anti-cancer therapeutic agents using cancer gene sets |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex |
| 08/22/2002 | US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research |
| 08/22/2002 | US20020114807 Administering drug comprising a substance that specifically recognizes extracellular domain of signal regulatory proteins and that inhibits functioning of pathologic myeloid cells |
| 08/22/2002 | US20020114806 Uses of mammalian genes and related reagents |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114799 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | US20020114772 Methods of modulating hair growth |
| 08/22/2002 | US20020114738 Include features that can enhance performance of the fluid transfer, referred to a pre-shooter stop, a butterfly/a cascade structures, a waste chamber inlet, stop chamber, a bifunctional flow through chamber and hydrophobic vent |
| 08/22/2002 | US20020114734 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization |
| 08/22/2002 | US20020112969 Using a biosensor for quantitative analysis of a reduced (or oxidised) form of a redox species in a cell having a working electrode and a counter electrode spaced about 10-500 microns; measuring a charge of the depleted redox species |
| 08/22/2002 | US20020112840 Die casting machine |
| 08/22/2002 | DE10106370A1 Oligonukleotidsonden zur Detektion von parodontopathogenen Bakterien mittels in situ-Hybridisierung Oligonucleotide probes for the detection of periodontal bacteria by means of in situ hybridization |
| 08/22/2002 | DE10106320A1 Erzeugung und Verwendung von Zufallsanordnungen klonaler Nukleinsäureinseln auf einer Oberfläche Production and use of random arrangements of clonal nucleic islands on a surface |
| 08/22/2002 | DE10106199A1 Verfahren zur Isolierung von Nukleinsäuren aus einer nukleinsäurehaltigen flüssigen Probe A method for isolating nucleic acids from a nucleic acid containing liquid sample |
| 08/22/2002 | DE10105339A1 Verfahren zur fälschungssicheren Markierung, fälschungssichere Markierung und Kit Method for tamperproof label, tamper-proof marking and Kit |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | CA2776701A1 T1r taste receptors and genes encoding same |
| 08/22/2002 | CA2440743A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | CA2440698A1 Method for detecting dna polymerisation |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438433A1 Methods for the diagnosis and treatment of tumors employing the hepsin gene |
| 08/22/2002 | CA2438420A1 Amplified cancer gene wip1 |
| 08/22/2002 | CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2438130A1 Quantitative epstein barr virus pcr rapid assay |
| 08/22/2002 | CA2438129A1 Radiative decay engineering |
| 08/22/2002 | CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | CA2438121A1 Oligonucleotide probes used to detect parodontopathogenic bacteria by in situ hybridization |
| 08/22/2002 | CA2437878A1 A method for the prediction of molecular interaction networks |
| 08/22/2002 | CA2437873A1 Neurotonin and use thereof |
| 08/22/2002 | CA2437807A1 Pin1 as marker for abnormal cell growth |
| 08/22/2002 | CA2437799A1 Fusion proteins based upon somatostatin receptors |
| 08/22/2002 | CA2437784A1 Pin1 as a marker for prostate cancer |
| 08/22/2002 | CA2437737A1 Methods and compositions of amplifying rna |
| 08/22/2002 | CA2437583A1 Dna markers for meat tenderness |
| 08/22/2002 | CA2437576A1 Method for evaluating therapeutic efficacy |
| 08/22/2002 | CA2437246A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | CA2436713A1 Proteins and nucleic acids encoding same |
| 08/22/2002 | CA2434264A1 An optical method for testing sensitivity of cells |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2433057A1 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 08/22/2002 | CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | CA2432111A1 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | CA2430726A1 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | CA2427587A1 Biological fluid analysis device |
| 08/22/2002 | CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | CA2335410A1 A role for the tat protein of hiv-1 in suppression of viral reverse transcriptase activity during late stages of viral replication |
| 08/21/2002 | EP1233076A2 Differential diagnosis for mycobacterial and pseudomonas species using species-specific upstream p34 gene region probes |
| 08/21/2002 | EP1233075A2 BDNF polymorphism and association with bipolar disorder |
| 08/21/2002 | EP1233074A1 Vegf responsive cell-based assay for determining vegf bioactivity |
| 08/21/2002 | EP1233073A2 Oligonucleotide for detecting salmonella and method of detecting salmonella |
| 08/21/2002 | EP1233060A2 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233058A1 Method of proliferating natural killer cells |
| 08/21/2002 | EP1233023A1 Transcription factor and dna thereof |
| 08/21/2002 | EP1232755A2 Anti-HIV agents |
| 08/21/2002 | EP1232502A1 Magnetic glass particles, method for their preparation and uses thereof |
| 08/21/2002 | EP1232395A1 Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample |
| 08/21/2002 | EP1232287A2 Oligomer array with pna and/or dna oligomers on a surface |
| 08/21/2002 | EP1232286A2 Test for micro-organisms |
| 08/21/2002 | EP1232285A1 CATALYTIC RNAs WITH AMINOACYLATION ACTIVITY |
| 08/21/2002 | EP1232284A1 Genomic polymorphism for predicting therapeutic response |
| 08/21/2002 | EP1232283A2 Detection method by pcr |
| 08/21/2002 | EP1232282A2 Automated method for identifying related biomolecular sequences |
| 08/21/2002 | EP1232281A1 Method for the determination of the concentration of micro-organisms |
| 08/21/2002 | EP1232280A2 Method for evaluating states of biological systems |
| 08/21/2002 | EP1232269A1 Method for purifying proteins |
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232261A2 Cloning and characterization of the cap gene promoter |
| 08/21/2002 | EP1232258A1 Colon tumour-associated antigens |
| 08/21/2002 | EP1232256A2 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 08/21/2002 | EP1232253A2 Crystallizable compositions comprising a caspase-7 |
| 08/21/2002 | EP1232245A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 08/21/2002 | EP1232185A2 Methods of inhibiting metastasis |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression |
| 08/21/2002 | EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 08/21/2002 | EP1232157A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 08/21/2002 | EP1231993A1 Improved column for dna separation by matched ion polynucleotide chromatography |
| 08/21/2002 | EP1231934A2 Methods of inhibiting atrophy or promoting hypertrophy |
| 08/21/2002 | EP1231836A2 Human ex vivo immune system |
| 08/21/2002 | EP1185546A4 High specificity primers, amplification methods and kits |